A short course of immunotherapy given before surgery eliminated detectable colon cancer in a majority of patients whose tumors lacked a key DNA repair mechanism, according to results published in the ...

The identification of rare genomic alterations in patients with colorectal cancer gives oncologists the opportunity to treat patients who otherwise might not have many options. When Mia Balko, 48, ...

Neoadjuvant therapy for patients with metastatic colon cancer with single-organ liver or lung lesions was associated with improved overall survival in comparison with adjuvant therapy, according to ...

People battling advanced colon cancers might have a new treatment option that could extend their survival, a new trial finds. The findings were present the at the annual meeting of the American ...

Better out than in, they say? At least that seems to be the general consensus amongst the who's who of the wellness community—where colonics seem to be all the rage. If you're not familiar with the ...

An interview with Dr. Nancy Baxter from the University of Melbourne in Melbourne, Australia, and Dr. Jeffrey Meyerhardt from Dana-Farber Cancer Institute in Boston, MA, co-chairs on “Adjuvant Therapy ...

A multidisciplinary team made up of doctors and scientists from the Hospital del Mar Medical Research Institute (IMIM-Hospital del Mar) and the Institute for Research in Biomedicine (IRB Barcelona) ...

The following represents disclosure information provided by authors of this manuscript. All relationships are considered compensated. Relationships are self-held unless noted. I = Immediate Family ...

Targeted therapies are a type of medicine used to treat cancer. They work differently than standard chemotherapy. Instead of killing all fast-growing cells or keeping them from dividing, targeted ...